Quince Therapeutics (QNCX) Total Debt (2023 - 2025)
Quince Therapeutics (QNCX) posted quarterly Total Debt of $12.4 million for Q4 2025, down 13.63% year-over-year from $14.3 million in Q4 2024, and down 29.4% quarter-over-quarter from $17.5 million in Q3 2025.
Quince Therapeutics (QNCX) Total Debt (2023 - 2025) Analysis & Trends
Quince Therapeutics' Total Debt history runs 3 years deep, the most recent figure standing at $12.4 million for Q4 2025.
- In Q4 2025, Total Debt fell 13.63% year-over-year to $12.4 million; the TTM figure through Dec 2025 stood at $12.4 million (down 13.63% YoY), while the FY2025 annual figure was $12.4 million, down 13.63% from the prior year.
- Total Debt for Q4 2025 stood at $12.4 million, down from $17.5 million in the prior quarter.
- The five-year high for Total Debt was $18.8 million in Q2 2024, with the low at $12.4 million in Q4 2025.
- The 3-year median for Total Debt is $17.0 million (2025), against an average of $16.2 million.
- The sharpest annual moves came in 2024 and 2025: Total Debt fell 18.32% in 2024, then grew 17.59% in 2025.
- Quince Therapeutics' Total Debt stood at $17.5 million in 2023, then dropped by 18.32% to $14.3 million in 2024, then fell by 13.63% to $12.4 million in 2025.
- Business Quant data shows QNCX's Total Debt at $12.4 million in Q4 2025, $17.5 million in Q3 2025, and $17.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.37 Mn |
| Sep 30, 2025 | 17.52 Mn |
| Jun 30, 2025 | 16.99 Mn |
| Mar 31, 2025 | 15.27 Mn |
| Dec 31, 2024 | 14.32 Mn |
| Sep 30, 2024 | 14.90 Mn |
| Jun 30, 2024 | 18.83 Mn |
| Mar 31, 2024 | 18.27 Mn |
| Dec 31, 2023 | 17.53 Mn |